Qi-man Sun
Key Laboratory Of Carcinogenesis And Cancer Invasion, Ministry Of Education
Zhongshan, 200032, China
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib response.
Journal: Cancer letters
Published: July 16, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancer.
Journal: Clinical and translational medicine
Published: October 13, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors.
Journal: Journal of translational medicine
Published: April 14, 2024
MCM3 promotes hepatocellular carcinoma progression via Epithelial-mesenchymal Transition through AKT/Twist signaling pathway.
Journal: Annals of hepatology
Published: March 11, 2024
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer.
Journal: Hepatology international
Published: April 26, 2023
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion.
Journal: Hepatology international
Published: August 17, 2022
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Journal: Nature communications
Published: August 08, 2022
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
Journal: Journal of hematology & oncology
Published: August 12, 2021
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Journal: Frontiers in immunology
Published: May 05, 2021
Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation.
Journal: Journal of Cancer
Published: February 20, 2021
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: January 31, 2020
Last Updated: 09/26/2026